On July 25, 2003, the U.S. House of Representatives voted 243-186 to approve legislation, which will allow importation of lower-cost prescription drugs from certain countries, including Canada. The International Prescription Drug Parity Act, which faces significant opposition from the U.S. pharmaceutical industry, still has to pass the Senate to become law.
It is illegal for Americans to import into the United States, prescription drugs that are ordered by phone, Internet or bought in person. However, according to the Canadian International Pharmacy Association, U.S. regulators traditionally have not enforced the law against individual purchasers.
The new U.S. law will allow the importation into the U.S., by retailers and distributors, of medicines that are made in foreign facilities, which are approved by the U.S. Federal Drug Administration.
For a copy of the legislation visit:
http://thomas.loc.gov/cgi-bin/query/D?c108:1:./temp/~c108X8Msuw::